Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu‐Asia Aging Study

Low‐density lipoprotein cholesterol (LDL‐C) levels are suggested to be associated inversely with Parkinson's disease (PD). To test the hypothesis that LDL‐C levels may increase PD risk, we studied a prospective cohort of 3,233 men (Honolulu‐Asia Aging Study) for whom the LDL‐C from fasting lipid profiles was obtained during 1991 to 1993. The cohort was followed longitudinally until 2001 for incident Parkinson's cases. During follow‐up, 41 men developed PD (18.4/10,000 person‐years). Although the incidence of PD increased with decreasing LDL‐C in a dose‐dependent manner, the association was only significant for men aged 71 to 75 years. In the latter group, risk of PD declined from 38.5/10,000 person‐years in men with LDL‐C levels <80 mg/dl to less than 9/10,000 person‐years for concentrations that were ≥140 mg/dl. After adjustment for age, smoking, coffee intake, and other factors, the relative odds of PD for men at the 80th versus the 20th percentile of LDL‐C (135 vs. 85 mg/dl) was 0.4 (95% confidence interval: 0.2, 0.9). This prospective study supports the hypothesis that low LDL‐C is associated with an increased risk of PD. Although confirmation is required, the underlying mechanisms may be useful in understanding key aspects of PD. © 2008 Movement Disorder Society

[1]  Y. Stern,et al.  Pathological correlates of extrapyramidal signs in Alzheimer's disease , 1997, Annals of neurology.

[2]  E. Parati,et al.  Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease. , 1993, Biochemical medicine and metabolic biology.

[3]  A. Jon Stoessl,et al.  Etiology of Parkinson's Disease , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[4]  Ward Cd,et al.  Research diagnostic criteria for Parkinson's disease. , 1990 .

[5]  H. Sagar,et al.  A data‐driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes , 1999, Movement disorders : official journal of the Movement Disorder Society.

[6]  C. Tanner,et al.  Epidemiology of Parkinson's disease and akinetic syndromes , 2000, Current opinion in neurology.

[7]  L. Heilbrun,et al.  The origins of epidemiologic studies of heart disease, cancer and osteoporosis among Hawaii Japanese. , 1985, Hawaii medical journal.

[8]  Lewis E Kazis,et al.  Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease , 2007, BMC medicine.

[9]  Cecil M. Burchfiel,et al.  Environmental, life-style, and physical precursors of clinical Parkinson’s disease: recent findings from the Honolulu-Asia Aging Study , 2003, Journal of Neurology.

[10]  Anthony H V Schapira,et al.  Etiology of Parkinson’s disease , 2006, Neurology.

[11]  D.,et al.  Regression Models and Life-Tables , 2022 .

[12]  C. Tanner,et al.  Frequency of bowel movements and the future risk of Parkinson’s disease , 2001, Neurology.

[13]  M. Hernán,et al.  Alcohol consumption and the incidence of Parkinson's disease , 2003, Annals of neurology.

[14]  K. Jellinger Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms? , 1999, Journal of neural transmission. Supplementum.

[15]  R. Mayeux,et al.  APOE genotype, plasma lipids, lipoproteins, and AD in community elderly , 1999, Neurology.

[16]  Richard W. Murrow,et al.  Lower low‐density lipoprotein cholesterol levels are associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[17]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[18]  R. Worth,et al.  Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration. , 1970, Journal of chronic diseases.

[19]  J. Jankovic,et al.  Parkinson's Disease & Movement Disorders , 2002 .

[20]  Daniel L. McGee,et al.  Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. , 1984, American journal of epidemiology.

[21]  C. Tanner,et al.  Association of coffee and caffeine intake with the risk of Parkinson disease. , 2000, JAMA.

[22]  D. Morens,et al.  Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. , 1994, American journal of epidemiology.

[23]  Nitin R. Patel,et al.  Exact logistic regression: theory and examples. , 1995, Statistics in medicine.

[24]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[25]  P. W. Lane,et al.  Analysis of covariance and standardization as instances of prediction. , 1982, Biometrics.

[26]  C. Poole,et al.  APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease. , 2004, Neurology.

[27]  Beate Ritz,et al.  Clinical characteristics in early Parkinson's disease in a central California population‐based study , 2005, Movement disorders : official journal of the Movement Disorder Society.

[28]  S. Czuczwar,et al.  Neuroprotective properties of statins. , 2005, Pharmacological reports : PR.

[29]  Chris Zarow,et al.  Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. , 2003, Archives of neurology.

[30]  P A Wolf,et al.  Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. , 1994, JAMA.

[31]  Albert Hofman,et al.  Serum cholesterol levels and the risk of Parkinson's disease. , 2006, American journal of epidemiology.

[32]  J. Dallongeville,et al.  Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. , 1992, Journal of lipid research.

[33]  E. Teng,et al.  The Cognitive Abilities Screening Instrument (CASI): A Practical Test for Cross-Cultural Epidemiological Studies of Dementia , 1994, International Psychogeriatrics.

[34]  C. Ward,et al.  Research diagnostic criteria for Parkinson's disease. , 1990, Advances in neurology.

[35]  D J Foley,et al.  Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. , 1996, JAMA.

[36]  Chris Zarow,et al.  Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis , 2003, Neurobiology of Aging.

[37]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[38]  C. Poole,et al.  APOE-ϵ2 allele associated with higher prevalence of sporadic Parkinson disease , 2004 .

[39]  J. Touchon,et al.  Mild extrapyramidal signs and functional impairment in ageing , 2002, International journal of geriatric psychiatry.

[40]  S. Fahn Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[41]  R. Abbott Logistic regression in survival analysis. , 1985, American journal of epidemiology.

[42]  K. Yano,et al.  Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study , 2001, The Lancet.